{"groups":[{"description":"Curcumin starting dose 2 grams orally in two divided doses (a.m., p.m.)","id":"FG000","title":"Curcumin"},{"description":"Curcumin starting dose 2 grams orally in 2 divided doses (a.m., p.m.) and Bioperine 5 mg orally twice daily","id":"FG001","title":"Curcumin + Bioperine"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"2"}],"type":"Disease progression"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"}],"type":"Non-compliant"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"16"},{"groupId":"FG001","numSubjects":"17"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"15"},{"groupId":"FG001","numSubjects":"15"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"2"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"Of 42 patients enrolled, 9 were excluded from the trial prior to group assignment because of screen failure.","recruitmentDetails":"Recruitment period: 11/2004 to 1/2008. All participants were recruited at UT MD Anderson Cancer Center."}